EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis

Felipe von Glehn iD, Nathalie Pochet, Bibek Thapa iD, Radhika Raheja, Maria A Mazzola, Sushrut Jangi, Vanessa Beynon, Junning Huang, Alessandro S Farias, Anu Paul, Leonilda M B Santos, Roopali Gandhi und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Felipe von Glehn und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology Unit-Department of Genetics, Microbiology and Immunology-Institute of Biology, University of Campinas, Campinas 13083-970, Brazil. Hauptthemen laut MEDLINE: Interleukin-27, Multiple Sclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, São Paulo Research Foundation, Center for Neurologic Diseases Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study was to examine whether myeloid dendritic cells (mDCs) from patients with multiple sclerosis (MS) and healthy controls (HCs) become similarly tolerogenic when exposed to IL-27 as this may represent a potential mechanism of autoimmune dysregulation. Our study focused on natural mDCs that were isolated from HCs and MS patient peripheral blood mononuclear cells (PBMCs). After a 24-h treatment with IL-27 ± lipopolysaccharide (LPS), the mDCs were either harvested to identify IL-27-regulated gene expression or co-cultured with naive T-cells to measure how the treated DC affected T-cell proliferation and cytokine secretion. mDCs isolated from HCs but not untreated MS patients became functionally tolerogenic after IL-27 treatment. Although IL-27 induced both HC and untreated MS mDCs to produce similar amounts of IL-10, the tolerogenic HC mDCs expressed PD-L2, IDO1, and SOCS1, while the non-tolerogenic untreated MS mDCs expressed IDO1 and IL-6R. Cytokine and RNA analyses identified two signature blocks: the first identified genes associated with mDC tolerizing responses to IL-27, while the second was associated with the presence of MS. In contrast to mDCs from untreated MS patients, mDCs from HCs and IFNb-treated MS patients became tolerogenic in response to IL-27. The genes differentially expressed in the different donor IL-27-treated mDCs may contain targets that regulate mDC tolerogenic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-27Multiple SclerosisHumansCells, CulturedCytokinesDendritic CellsLeukocytes, MononuclearT-LymphocytesInterleukins

Stichwörter der Autor:innen

IL-27Programmed Death 1 receptor (PD1)Programmed Death Ligand 2 (PD-L2)innate immune responselymphoproliferative assaymyeloid dendritic cells (mDCs)relapsing-remitting multiple sclerosis (RRMS)

Substanzen

CytokinesInterleukin-27MYDGF protein, humanInterleukins

Autor:innen und Institutionen

  • Neuroimmunology Unit-Department of Genetics, Microbiology and Immunology-Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MS 02115, USA.

ORCID-Profile: Felipe von Glehn, Bibek Thapa

Förderung

  • NIH HHS
  • São Paulo Research Foundation
  • Center for Neurologic Diseases Foundation
  • NIH/NIEHS
  • NIH/NIAID
  • NMSS-IPMSA
  • NIH/NINDS
  • NMSS

Zitieren

APA

von Glehn, F., Pochet, N., Thapa, B., Raheja, R., Mazzola, M. A., Jangi, S., Beynon, V., Huang, J., Farias, A. S., Paul, A., Santos, L. M. B., Gandhi, R., Murugaiyan, G., Weiner, H. L., & Baecher-Allan, C. M. (2023). Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098000

Vancouver

von Glehn F, Pochet N, Thapa B, Raheja R, Mazzola MA, Jangi S, et al. Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098000

BibTeX
@article{vonGlehn2023,
  author = {von Glehn, Felipe and Pochet, Nathalie and Thapa, Bibek and Raheja, Radhika and Mazzola, Maria A and Jangi, Sushrut and Beynon, Vanessa and Huang, Junning and Farias, Alessandro S and Paul, Anu and Santos, Leonilda M B and Gandhi, Roopali and Murugaiyan, Gopal and Weiner, Howard L and Baecher-Allan, Clare M},
  title = {Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098000}
}
Kostenlos starten →